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A mechanistic analysis of the National Cooperative Dialysis Study
(NCDS). The purpose of the NCDS was to determine the probability of
clinical failure (PF) as a function of the level of dialysis and protein
catabolic rate (pcr, glkglday). The level of dialysis prescribed in the
NCDS was mechanistically defined as KtIV (product of dialyzer urea
clearance and treatment time divided by body urea volume), which
exponentially determines decrease in BUN during dialysis and is also a
mathematical analogue of pcr, BUN. Mechanistic analysis (MA)
showed that PF was a discontinuous function of Kt/V as it was
prescribed in the NCDS and that a dependence of PF on pcr could not
be assessed because of the study design. The MA results were com-
pared to those reported with statistical analysis (SA) that used BUN
and pcr. The SA predicts PF is strongly dependent on pcr with
nutrition-dependent high PF for pcr  0.8 and low PF with high pcr and
intensive dialysis. The MA suggests SA results may not be valid
because a continuous outcome function is assumed and, due to study
design, Kt/V was a dependent variable of pcr and these two variables
cannot be clearly separated by analysis of BUN and pcr alone.
Une analyse mécaniste de Ia National Cooperative Dialysis Study
(NCDS). Le but de Ia NCDS a été de determiner Ia probabilité d'un
échec clinique (PF) en fonction des niveaux de dialyse et de Ia vitesse
de catabolisme des protéines (pcr, g/kgljour). Le niveau de dialyse
prescrit lors de Ia NCDS était défini de facon mCcaniste comme Kt/V
(produit de Ia clairance de l'urée du dialyseur et du temps du traitement
divisé par le volume corporel de l'urée), lequel determine de facon
exponentielle Ia diminution de BUN au cours de la dialyse et est
également un analogue mathématique de pcr, BUN. L'analyse
mécaniste (MA) a montré que PF Ctait une fonction discontinue de
Kt/V, tel qu'il dtait present lors de Ia NCDS, et qu'une dépendance de
PF sur pcr ne pouvait étre prdcisée en raison du schema de l'étude. Les
résultats de MA ont été compares a ceux rapportés par analyse
statistique (SA) lesquels utilisaient BUN et pcr. SA prédit que PF
depend fortement de pcr, avec un PF dlevé, dCpendant de l'alimenta-
tion, pour pcr 0.8, et un PF bas avec un pcr dlevd et une dialyse
intense. La MA suggére que les résultats de SA pourraient n'être pas
valables car elle suppose le devenir comme une fonction continue, et en
raison du schema de l'étude, Kt/V était une variable dépendante de per.
Ces deux variables ne peuvent étre clairement separees par l'analyse de
BUN et de pcr individuellement.
The concept of a National Cooperative Dialysis Study
(NCDS) arose from the National Institutes of Health-sponsored
conference on Adequacy of Dialysis held in 1975 [1]. The
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persisting pathophysiology of multiple organ systems in dia-
lyzed patients was reviewed in depth at that conference, and it
was concluded that a carefully controlled multicenter coopera-
tive study was required to determine if quantitative relation-
ships between residual morbidity and the magnitude of dialysis
prescribed could be established.
The NCDS undertaken subsequently was a large-scale, care-
fully controlled study with comprehensive monitoring of multi-
pie treatment and outcome variables [2]. The probability of
clinical outcome failure in dialyzed patients as a function of
multiple treatment variables has been determined by stepwise
logistic regression, which is similar to ordinary multiple linear
regression [3]. The statistical model predicts that failure is very
high with protein intake less than .8 g/kg/day due to inadequate
protein nutrition and that minimal failure is associated with high
levels of protein intake (1.1 to 1,6 glkg!day) and intensive
dialysis [41 when quantitatively interpreted.
Consideration of the mechanisms of uremia, nutritional re-
quirements, and rates of hydrogen ion, potassium, and phos-
phate loading at high levels of protein intake results in some
skepticism with regard to these statistically derived results. A
reasonable approach would suggest that if the statistical results
are correct, it should be possible to reach the same conclusions
by mechanistic analysis of the nutritional and dialytic parame-
ters. The following is the result of such a mechanistic analysis.
Design of the study
It is necessary to review the design of the NCDS to elucidate
the mechanistic interrelationships between the dialysis treat-
ment and nutritional variables. The variable volume urea ki-
netic model [5, 6] was used to design and control the NCDS.
The clinical rationale for this model was based on two concepts:
1) Both inadequate and excessive protein intake are common
and undesirable in dialysis patients and, therefore, dietary
protein intake, as measured by the kinetically determined
normalized protein catabolic rate (see Eq(9) Appendix, pcr,
glkglday), should be documented to be within the usually
accepted normal range of 1.1 .3; and 2) the magnitude of
dialysis required for adequate therapy is dependent on the pcr
and should be sufficient to result in a relatively fixed midweek
predialysis BUN (CO2. mg/dl) at the prevailing pcr for individ-
ual patients. Thus, the urea model was used to determine pcr
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and the level of dialysis required to achieve specified BUN
levels with thrice weekly treatments.
The study was designed initially to compare outcome with
two nominal CO2 levels of 70 and 120 mg/dl over the targeted
pcr range 1.1 .3 g/kg/day. However, at the extremes of pcr, it
was apparent that achieving these fixed CO2 levels would be
very difficult technically. At low pcr, extremely low dialyzer
clearances would be required to achieve CO2 of 120 while at
high pcr, very high clearances would be required to achieve
CO2 of 70 mg/dl. Consequently, the time averaged concentra-
tion (TAC) of BUN was used and targeted at 50 and 100 mg/dl.
This resulted in targeting BUN at the middle of the sawtoothed
concentration profile rather than the maximum CO2 values, was
a little less sensitive to the extremes of pcr and more feasible
technically. However, there was clear separation of both CO2
and TAC between the low and high BUN therapies and the CO2
values (averaging — 70 and 110) will be used primarily in this
analysis because they are clinically more familiar and mathe-
matically can be related more directly to the level of prescribed
dialysis. As will be shown quantitatively below, this study
design resulted in a linear dependence on pcr of the amount of
dialysis prescribed so that the treatment and nutritional varia-
bles cannot be treated as independent variables.
Control of middle molecules was also partially addressed in
the study design. The low and high BUN groups were each
divided into long and short treatment time groups so that the
effect of middle molecule removal could be evaluated, middle
molecule flux being more time dependent. The four experimen-
tal groups thus established were: Group 1 =TAC of 50 (CO2 -
70)and treatment time 4.5 to 5.0 hr; Group 2 = TAC of 100 (CO2
110) and treatment time 4.5 to 5.0 hr; Group 3 = TAC of 50
(CO2 — 70) and treatment time 3 0.5 hr; Group 4 = TAC of
100 (CO2 110) and treatment time 3 0.5 hr.
Mathematic interrelationships between dialysis
and nutritional variables
The urea model was used to measure pcr in each patient and
to prescribe two levels of dialysis corresponding to CO2 values
of — 70 or 110 mgldl. The study results show this was fairly
well achieved with an average difference in CO2 of 38 mg/dI
between the low and high BUN target levels over a pcr range of
0.6 to 1.4 glkglday (see Fig. 3). Thus, the study provided two
clearly separated levels of therapy, as defined by BUN, over a
wide pcr range and statistical analysis of outcome was based
primarily on the BUN and pcr variables.
The physiologic mechanisms by which dialysis controls ure-
mic morbidity remain unknown. The BUN has not been shown
to have concentration-dependent toxicity in the range studied,
but is traditionally considered to be a marker molecule to
indicate the level of dialysis prescribed. The mechanism by
which dialysis controls BUN in an individual patient can be
quantified from the total urea clearance prescribed, which is
given by the product of the dialyzer urea clearance (K, mllmin)
and the treatment time (t, mm). This parameter can be gener-
alized by normalization to the urea distribution volume (V, ml)
as Kt/V, a dimensionless parameter that describes the pre-
scribed fractional clearance of total body water. The mathemat-
ical meaning of Kt/V is shown in Eq(1) of the Appendix where
it can be seen to exponentially determine the total decrease in
BUN during a dialysis treatment.
CO2 mg/d/
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0.5 0.7 0.9 1.1 1.3
pcr, 9/kg/day
Fig. 1. The relationship of KtIV to pcrfor constant CO2.
Although Kt/V in this analysis refers specifically to the
fractional urea clearance, it also provides an index to propor-
tionate fractional clearances provided by the dialyzer of all low
molecular weight toxic substances that may be accumulating in
uremic plasma. In this sense, KtIV can be considered to be a
more fundamental mechanistic parameter of the level of dialysis
prescribed compared to BUN which represents the concentra-
tion of a single relatively non-toxic solute. Thus, Kt/V is a
basic, generalizable dialysis parameter and serves as the basis
of the mechanistic analysis reported here.
If Kt/V and CO2 were similarly related to the nutritional pcr
parameter, these conceptual differences would be of no signif-
icance and Kt!V and CO2 could be considered to be inter-
changeable dialysis parameters. However, it can be shown that
mathematically Kt/V and CO2 have quite different functional
relationships to pcr. Although the rigorous variable volume
urea model was used to control the study, these differing
functional relationships can be illustrated using a truncated
version of the model. The key relationships are listed below,
while formal development can be found in the Appendix.
— ln [1 — .49 (pcr — .16)
V [ CO2
(2) CO2 .49 1/ (1 — e (pcr — .16)
Sensitivity of BUN to pcr and magnitude of dialysis, Kt/V
Equation (1) demonstrates how Kt/V was prescribed as a
function of pcr with CO2 held relatively constant at levels of
70 and - 110 mgldl. Numerical solution of this approximation
expression for constant CO2 values over a wide range is shown
in Figure 1. The loci of these curves is of considerable interest
and demonstrate the complex relationships of CU2, KtJV, and
pcr.
Consider first the lower bound of pcr shown, .5 g/kg/day. It is
apparent that, due to a low urea generation rate, CO2 is very sensitive
to slight changes in KtJV in the target CO2 range of 70 to 120 mg/dl.
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Fig. 2. Comparison of pcr to pcrw.
separation of Kt/V with values of .27 and .15 shown for the low and
high BUN target values, respectively,
At the upper bound of per, the constant BUN lines become
widely separated with a much larger increase in KtIV for a given
decrease in BUN. This is due to the high interdialytic urea
generation rate and the need to reduce BUN to very low
end-dialysis levels so that the interdialytic rise will not exceed
the pre-dialysis target level. Since removal is first order (that is,
proportional to BUN), it becomes progressively less efficient as
BUN falls so that therapy represented by KtIV increases
sharply as BUN decreases. This effect can be seen in Figure 1
where Kt/V increases from .71 to 2.02 as CO2 is reduced from
120 to 70 mgldl at per = 1.4 glkg/day.
The actual regression of KtIV on per found in the NCDS for
the groups 1,3 and 2,4 patients are also depicted as dotted lines
on Figure 1. The slopes are linear and somewhat shallower than
the curves of constant BUN at 70 and 120 mg/dl. As noted
earlier, this reflects the decision to hold TAC rather than CO2
constant at two levels that somewhat flattened and linearized
the dependence of prescribed KtIV on per. However, the
general relationship of reduced KtIV at low per, irrespective of
the BUN target, and marked separation of KtIV between low
and high BUN groups at high per is still readily apparent. At per
=
.6, the Kt/V are .34 and .55 for the high and low BUN groups,
respectively, while at per = 1.4, these values are .74 and 1.59.
The actual KtIV vs per lines, as depicted in Figure 1, are
linear and yield regressions of:
KtIV = 1.29(pcr) — (.22 .26), r = .813, P <0.001 (groups
1,3)
Kt/V =
.51(pcr) + (.03 .14), r = .758, P < 0.001 (groups
2,4)
The slopes of these regressions are constants defining the
level of treatment (KtIV) prescribed relative to per (KtIV Ipcr,
kg day g') and, as such, are fundamental Treatment/Nutri-
tion (TIN) constants for the low and high BUN groups. The
value of T/N for groups 1,3 was two and a half times that for
groups 2,4, indicating that to maintain a patient in group 1,3,
treatment had to increase 2.5 times more in response to





40 CO2 22.8 (pcr) + (48.7 10.7)
r =
.522, P < 0.001
increased per compared to a patient in groups 2,4. However,
the absolute level of treatment prescribed differs very little
between groups 1,3 and 2,4 at low per values.
The determining factors of BUN are nutrition (in the form of
protein and its catabolism) and treatment related. In fact, the
BUN level will reflect the level of protein catabolism relative to
the treatment provided:
BUN = Nutrition = per
Treatment \ KtIV
The BUN provides no insight into how treatment varies
relative to nutrition since the two variables are not separated.
The level of treatment, when expressed as the mechanistic
parameter Kt/V, is clearly separated from the nutritional vari-
able and provides a non-ambiguous parameter of treatment.
Clinical consideration of treatment separation at low and
high pcr
The relationship of Kt/V to per shown in Figure 1 for the
groups 1,3 and 2,4 patients can be better appreciated in a
clinical context by examination of the actual treatment pre-
scribed fora patient of average size at low and high per. At per
=
.6, the KtIV values are .55 and .34 for the low and high BUN
groups. Assuming an average V 37,000 ml and t 234 mm
(3.9 hr), it can be readily calculated that dialyzer clearances of
84 and 51 ml/min would be prescribed. These clearances are
minimally separated and typical of the low efficiency parallel
ridge support Kiil dialyzers widely used 20 years ago with
treatment times of 8 to 12 hr, which results in Kt/V values of -
1.0. Thus, in both groups 1,3 and 2,4 patients with low per, the
average treatment consisted of dialysis for — 4hrs with dialyzer
efficiency about one-half to one-third of modern dialyzers. The
marked reduction in treatment at low per for both high and low
BUN groups in the NCDS is more clinically apparent when
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0.7 0.9 1.1 1.3 1.5
pcr, a/kg/day
Fig. 3. The domains of groups 1,3 and 2,4 patients as a function of pcr
and CO2. Symbols are: •, group 1,3 success; •, group 2,4 success; 0,
group 1,3 failure; D, group 2,4 failure.
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patients are also depicted to portray visually the relationship of
these to the level of dialyssis prescribed. The loci of these
curves again demonstrate that CO2 is a complex function of
both Kt/V and pcr and does not provide a clear separation of
dialysis and nutritional variables.
Analysis of outcome with B UN and pcr vs. analysis with
KtIV, BUN, and pcr
Equations (1) and (2) show that there are three mathemati-
cally and mechanistically related kinetic parameters describing
the levels of protein nutrition and dialysis in this study. The
statistical analysis was based on two kinetic varibles, BUN and
pcr standing alone [31, while the mechanistic analysis reported
here is based on all three of the interrelated variables Kt/V,
BUN, and pcr clearly separated. Further simplification and
rearrangements of Eq(1) are helpful to clarify the significance of
these differences between the statistical and mechanistic anal-
yses. Simplification of the functional relationships between





(5) pcr = f3 [(Kt/V) BUN]
Equation (3) shows that analysis of outcome dependence on
Kt/V can also be considered mathematically to be equal to
analysis of outcome as a function To analyze outcome
BUN
as a simultaneous function of all three variables it is necessary
to clearly separate each variable. This was accomplished in two
steps in the mechanistic analysis by first analyzing outcome as
a function of Kt/V and then as a function of Kt/V, BUN, and
pcr using the graphic relationships between the three variables
in Figure 6.
In the statistical analysis, only BUN and pcr are included in
outcome analysis and thus only two of the three interrelated
nutritional and treatment variables are included. Although it
would appear that BUN and pcr are discrete, separated treat-
ment and nutritional variables, Eqs (4) and (5) show that BUN
is a function of pcr/(Kt/V) while pcr is a function of
(KtIV)(BUN). This can be perceived more clearly from consid-
eration of the logistic regression equation used for statistical
analysis [3]:
(6) ln [F/(l — F)] = /30 + 131BUN + /32pcr. . . + /3k<ki
The difficulty with considering BUN and pcr as discrete
independent variables can be best visualized by substituting
Eqs (4) and (5) into (6), which results in
(7) ln [FI(l — F)] /30 + /31 [f2(pcr/(Kt/V))] +
/32 [13 [(Kt/V)(BUN)]].. + J3kxki
It is apparent from Eq(7) that because of the kinetic relation-
ships BUN and pcr cannot be considered to be separated
independent variables in the logistic regression, although they
appear to be. Each of these variables is dependent on the other
variable as a function of Kt/V and, as discussed earlier, Kt/V
1'I•I'I•I• I
0.4 0.6 0.8 1.0 1.2 1.4
KtN, dimensionless
Fig. 4. The relationships between probability of failure I (PFJ) and
probability of failure 2 (PF2) to the level of dialysis, Kt/V.
At pcr = 1.4, similar calculations show that the average
patient in the low BUN groups would require dialyzer clearance
of 245 ml/min, while in the high BUN groups a clearance of 108
ml!min would be prescribed. Thus, prescribed clearance ranged
from 84 to 245 ml/min as a function of pcr in groups 1,3, but
covered a much smaller range in groups 2,4, from 51 to 108
mi/mm.
The relationship of BUN to pcr at constant level of dialysis,
Kt/V
Equation (2) above demonstrates the approximate relation-
ship of CO2 to pcr as a function of Kt/V. The expression
indicates that when Kt/V is held constant, CO2 will increase
linearly with pcr, and the slope will approximately equal .49
[11(1 — e ]. Examination of the slope term shows that it will
decrease as Kt/V increases and approach a limit of .49 when
Kt/V is very large and e — 0. Thus, if lines of constant
treatment (Kt/V) are plotted on pcr, CO2 coordinates there will
be marked separation at low Kt/V values with lines merging to
approach CO2 = .49(pcr — .16) as Kt/V increases. This will
provide a graphic portrayal of the simultaneous relationships
between pcr, CO2 and Kt/V as the level of dialysis (Kt/V) is
incresed over the entire pcr, CO2 domain and will be used in the
course of discussion of pcr, CO2 mapping of NCDS data (Fig.
6). In this figure, the rigorous urea model was solved for CO2 for
the case of V = 37,000 ml, residual renal urea clearance (Kr)=0,
interdialytic weight gain = .75 kg/day and with typical asym-
metric thrice weekly treatment over a wide range of pcr and
Kt/V values. The original data points for groups 1,3 and 2,4
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was a dependent variable of per and BUN due to the study
design. We believe it is particularly troublesome in the statisti-
cal analysis to consider per as a discrete variable having specific
nutritional significance with respect to outcome of therapy in
the context of this study. This will be considered more fully
later.
Methods
The mechanistic analysis of outcome is based on the mean
values of Kt/V, per, and CO2 for each patient throughout the
experimental phase of the study.' Clinical outcome was com-
prehensively monitored and detailed reports on the many organ
systems describing the magnitude of residual morbidity for
individual organ systems provide a wealth of detailed
pathophysiologic information [2]. However, to systematically
analyze the four therapy groups, an overall description of
morbidity was required and developed [3] based on two quan-
tifiable criteria, medical drop out (MDO) and hospitalization
(H), which could be used to categorize the overall outcome for
each patient. The MDO criterion was based on the appearance
of de novo clinical abnormalities or worsening of residual
morbidity in any organ system. The clinical abnormalities
resulting in MDO were largely gastrointestinal (anorexia, nau-
sea, vomiting, and GI bleeding), cardiac (pericarditis, pleuritis,
sudden death, and congestive heart failure) and hematologic
(increased anemia and transfusion requirements). Patients with-
drawn from the study due only to MDO were categorized as
falling into failure mode 1 (Fl). A second failure mode (F2) was
defined comprised of H and/or MDO so that if a patient
experienced either H or MDO the outcome was categorized as
F2. The success/failure modes 1 and 2 classification for each
patient used for the mechanistic analysis was obtained from
NCDS staff and therefore identical to that used in the statistical
analysis of the data.
Clinical outcome as a function of Kt/V
The entire experimental data base was ordered by increasing
values of mean Kt/V for individual patients and outcome for
each patient recorded as success, failure 1, or failure 2. The
'These values were computed from the kinetic data contained in the
final raw data files of the NCDS at the close of the study and obtained
from the Harvard Health Sciences Computer Facility. The quality of
kinetic data was monitored throughout the study on each patient by
interactive modeling sessions between the participating center and the
kinetic control facility, Quantitative Medical Systems. Additionally, the
Harvard Health Sciences Computing Facility performed kinetic error
detection evaluations throughout the study. Consequently, the inci-
dence of kinetic data entry and coding errors in the final raw data base
was very low at .26 and .98%, respectively [7]. The pcr and CO2 were
each measured 20 to 30 times over the six-month experimental period
and Kt/V reported 70 to 80 times for each patient. The data base used
for this mechanistic analysis underwent subsequent additional data
processing at Harvard, during which additional data entry and coding
errors were corrected for creation of the final data base used for
analyses by the NCDS. Although the kinetic data base used for the
mechanistic analysis is not quite identical with the final clean data base,
it is not reasonbie to think that significant differences would result in the
mean kinetic parameters calculated here in view of the large number of
measurements comprising each mean value and the demonstrated low
incidence of kinetic entry and coding errors. We assume responsibility
for the quality of these data and for our analysis and interpretation,
which may not reflect the opinion of the NCDS staff.
ordered data was divided into ten equal groups of 16 patients
and then the mean Kt/V and fraction of patients exhibiting Fl or
F2 were calculated for each group. These data were then used
to analyze the dependence of outcome failure on Kt/V.
Comparison of PCR/wt and PCR/(V/.58)
The final data analysis with the statistical model [3] was based
on pcrw, PCR divided by body wt, while the therapeutic
recommendations resulting from the statistical model [4] were
based on per, PCR divided by V/.58. The mechanistic model
analysis and therapeutic recommendations are based entirely
on per. Since two definitions of normalized net protein catabolic
rate (considered equivalent to dietary protein intake under
these conditions) are used for analysis and therapy, it is
important to examine how they relate to each other.
The term pcrw is calculated from
PCR kABUNVpcrw = =
wt wt
where L\BUN is the interdialytic rate of increase in BUN, V is
urea distribution volume and k is an appropriate proportionality
constant (see Appendix for more detail.
The per term is calculated from
PCR kzBUN•Vper = _________ = .58k ABUN
V/.58 VI.58
The definitions of pcrw and per are not identical. In the case
of pcrw, the k LBUN term is multiplied by V/wt while in the
case of per, the k . LBUN term is normalized to V/.58 and V
cancels out of the expression. Although both definitions include
BUN in the calculation, they differ with respect to V/wt.
The overall relationship between per and pcrw can be seen by




When pcr/pcrw is unity, wt must be equal to (V/.58). The
ratio of pccr/pcrw for all NCDS experimental phase data was
1.00 .15, M s, N = 162 and reflects the mean ratio of V/wt
=
.59 .08 in the data base. Thus, overall, per, and pcrw agree
well, since the normalization term V/.58 closely approximates
the actual mean value of .59 for V/wt in the data base.
Linear regression of per on pcrw in the data base is shown in
Figure 2 and given by
(11) per = .6Opcrw + (.40 .23), N = 162, r = .68
The regression of per on pcrw is compared in Figure 2 to a
slope 1.0 regression through the origin. The actual regression
line intersects the slope 1.0 regression at the point where per =
pcrw 1.0 and is rotated clockwise around this point. The
regression difference of (per — pcrw), g/kg/day, is + .2 when
pcrw =
.5, zero when pcrw = 1.0, and — .2 when pcrw = 1.5
glkglday. Thus, there is a small, predictable difference between
per and pcrw at the lower and upper bounds of their values.
However, as will be shown later (Fig. 5), both the mechanistic
and statistical models show a similar dependence of outcome on
either BUN and per or BUN and pcrw if outcome is assumed to
be continuous function of either of these parameters.
There is no disagreement with NCDS staff conclusions that
per is clearly preferable to perw for prescription of protein
(8)
(9)
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0.9 1.1 1.3
PCR, PCR/wt
Fig. 5. Prediction of failure by statistical analysis (SA) compared to
mechanistic analysis (MA) with continuous function assumed.
intake and dialysis. Lowrie and Teehan recommend use of pcr
[4], as do we because of the rigorous mathematical relationships
between CO2 (and TAC), pcr, and Kt!V as depicted in Figure 6.
For example, if pcr is known and a specific CO2 targeted, it is
possible to read directly from Figure 6 the KtIV required. When
pcrw is used, there is a similar approximate relationship be-
tween these variables, but it may vary considerably in individ-
ual patients depending on body water content.
Results of mechanistic analysis
The simplest portrayal of outcome might be that shown in
Figure 3 where the groups 1,3 and 2,4 domains are shown on
pcr, CO2 coordinates, and definition 2 success and failure are
coded. It is apparent that probability of failure 2 (PF2, dimen-
sionless) was much higher for groups 2,4 than 1,3 patients with
pcr> .80 with PF2 values of .52 and .13, respectively. It is also
apparent that PF2 was high (PF2 .75) in both high and low
BUN groups when pcr < .80. This is quite puzzling conceptu-
ally in that it suggests that PF2 might be BUN dependent for pcr
> .80 and BUN independent for pcr < .80. A possible interpre-
tation is that two mechanisms of failure are involved: 1) With
low pcr there is failure due to inadequate protein nutrition; 2)
with adequate pcr, failure is dialysis dependent.
The results of analysis of PF1 and PF2 as functions of KtIV
are shown in Figure 4. The relationships are similar for PF1 and
PF2 so only the more inclusive PF2 will be discussed in detail.
What is clear from Figure 4 is that there was persistent high PF2
(57% failure) at Kt/V values from .4 to .8, which dropped
abruptly to low levels (13% failure) when Kt/V values exceeded
.9 (from .9 to 1.5). Within these two Kt/V ranges there was no
significant relationship between morbidity and KtIV (regression
analysis shows zero slope in each range). Consequently, Figure
4 indicates a step function relating morbidity to normalized
treatment and thus shows that the relation of morbidity to the
0.5 0.7 0.9 1.1 1.3 1.5
per, g/kg/day
Fig. 6. The distribution of groups 1,3 and 2,4 patients with respect to
per, GO2, and Kt/V. Symbols same as Fig. 3.
level of treatment cannot be considered to be a continuous
function.
The data depicted in Figure 4 can be mathematically analyzed
in a variety of ways, yielding highly significant statistical
relationships. If a linear dependence of PF2 on Kt/V is assumed
the resulting regression equation is
PF2 =
.904 —
.64l(Kt/V), r .883, P < 0.001
If PF2 is assumed to exponentially approach zero, the result-
ant function is
PF2 = l.797e_2239t, r = .858, P = 0.002
These two regression curves are shown on Figure 4 and
obviously fit the data to continuous functions reasonably well.
Inspection of the data, however, shows that they conform to a
discontinuous step function with sharp decrease in PF1 and PF2
in the region of Kt/V = .80. It is apparent that highly significant
continuous functions can be found to describe the relationship
because the data distribution conforms to essentially two clus-
ters of points, which are widely separated on both the ordinate
and abscissa.
Equation (3) shows that analysis of outcomes as a function of
Kt/V is mathematically equal to analysis of outcome as a
function of pcr and BUN. Therefore, it would be expected that
if outcome is assumed to be a continuous function of Kt/V and
outcome predicted by this analysis is transformed to pcr, TAC
coordinates, the resulting outcome plot should be very similar
to that resulting from the logistic statistical analysis based on
TAC, pcrw. In other words, both analyses should give very
similar results when continuous functions are assumed to
describe the relationships since both analyses are based on pcr
or pcrw and BUN or their mechanistic analogue, KtIV.
Figure 5 demonstrates the similarity in mechanistic and
statistical prediction of outcome based on Kt/V or PCR/Wt,
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sion above was taken to be the regression of PF2 on Kt/V,
solved for constant levels of failure ranging from .75 to .10, and
then Kt/V was transformed to per, TAC coordinates. The
resultant constant outcome curves are plotted in Figure 5 along
with constant outcome curves calculated from the logistic
statistical model regression coefficients 3] fort =3.9 hr and no
prehospitalization. In Figure 5A the abscissa is expressed as
1/per for the mechanistic Kt/V regression and wt/PCR for the
logistic statistical analysis (SA). The statistical outcome curves
are linear since the data was actually fit to the linear statistical
model as Wt/PCR [3], while the MA outcome curves are
nonlinear since Kt/V relates directly, not reciprocally, to per. In
Figure 5B where the abscissa is expressed as per and PCR/wt,
the MA curves are linear while the statistical curves are
nonlinear, the inverse of Figure 5A.
It is apparent from the curves in Figures 5A and B that
mechanistic analysis with Kt/V alone gives results very similar
to logistic statistical analysis with Wt/PCR and TAC alone when
continuous functions are assumed for both analyses. The loca-
tion of the constant outcome curves on per, TAC coordinates
are nearly identical but curvilinear or linear depending on
whether or not per and pcrw are expressed reciprocally. As
noted above, the analyses agree well because per and BUN are
an analogue of Kt/V. However, mechanistic analysis of out-
come as a function of the Kt/V analogue, which can be readily
visualized graphically in Figure 4, shows outcome is a discon-
tinuous function of Kt/V and hence of per and BUN.
It does not follow that Kt/V is the sole parameter determining
the clinical outcome of dialysis therapy. The kinetics and study
design resulted in a strong relationship between prescribed
Kt/V to per and CO2 so that outcome dependence on Kt/V must
also be analyzed with respect to per and CO2. The distribution
of all patients (with success/failure coded) is depicted in Figure
6 on per, CO2 coordinates, with Kt/V identity lines depicted as
well. This plot reveals the graphic interrelationships of these
three variables clearly separated. Inspection of these data
shows that both per and CO2 distribute over a wide range for
Kt/V < .80. The mechanistic reasons are that, due to the kinetic
relationships and the study design, all of the groups 2,4 patients
with high BUN have low Kt/V values at all levels of per and the
groups 1,3 patients with low per have low BUN and Kt/V
values. Thus, it can reasonably be concluded that levels of
prescribed Kt/V < .80 provide inadequate dialysis with high
probability of failure irrespective of per (and hence BUN). This
provides a simple, unified explanation for the puzzling outcome
results depicted in Figure 3 with high failure rates in all groups
2,4 patients and in groups 1,3 patients with low per.
In contrast to the case for Kt/V < .80, inspection of Figure 6
reveals that when Kt/V> .80, the data base is comprised almost
entirely of groups 1,3 patients with per > .80 and CO2 tightly
constrained to < 90 mg/dl at maximal per. There were no
patients treated with high Kt/V who had high BUN. The
mechanistic reason for the constraint on BUN was that the
study design required that Kt/V increase linearly with per (Fig
1) to hold TAC constant which resulted in a minimal positive
slope on CO2 as a function of per. In view of the study design
and resultant data distribution, clinical outcome results are
unknown for patients treated with Kt/V > .80 and CO2 values
higher than those studied in the groups 1,3 patients. The NCDS




mechanistically would be comprised of therapy with low levels
of (Kt/V)/pcr which were rigorously excluded by the study
design when Kt/V exceeded .80.
It should also be noted in Figure 6 that no patients with per <
80 were treated with prescribed Kt/V> .80. Again, because of
a study design that resulted in low prescribed Kt/V for all
patients at low per, the NCDS must be considered silent in the
domain of per < .80 and Kt/V > .80.
Finally, it can be noted in Figure 6 that the maximal Kt/V
prescribed was 1.5. Since PF2 was constant at .13 over the
Kt/V range 0.8 to 1.5 (with CO2 constrained as described
above), it can be tentatively concluded that levels of Kt/V> 1.5
may be excessive dialysis and not likely to effect a decrease in
PF2 below the .13 level.
Mechanistic outcome failure probability map
The concept of an outcome failure probability map on per,
CO2 coordinates has considerable clinical value. The coordi-
nates for individual patients provide ready visualization of the
risk of treatment failure in terms of the nutritional parameter
and the BUN, which is a familar traditional parameter of
treatment and which, under well-defined conditions with re-
spect to Kt/V, can serve as a rigorous surrogate for the level of
dialysis prescribed.
A probability of failure 2 map was constructed from the data
in Figures 4 and 6 and is depicted in Figure 7. Domains A and
B were not included in the NCDS by design and are therefore
considered to be undefined by the study. Domain C is consid-
ered to be possibly an area of excessive dialysis bounded by .8
< per < 1.4 and Kt/V > 1.5. Domain D with Kt/V < .70
represents inadequate dialysis with constant PF2 = .52 .13, M
2 SD, as seen in Figure 4. A transitional zone is depicted



















Fig. 7. Probability of failure 2 (PF2) domains defined by mechanistic
analysis of the NCDS.
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nuity region of the PF2 function in Figure 4. Finally, Domain E
is the area of adequate dialysis defined by the NCDS with
constant PF2 of .13 .07, M 2 SD. The domain is bounded by
.9 < Kt/V < 1.5 with CO2 = 22.8pcr + (48.7 10.7) as shown
in Figure 3.
Discussion
It is apparent that mechanistic and statistical analyses lead to
very different conclusions regarding the functional relationship
of outcome failure to the level of dialysis and protein intake
prescribed. A mechanistic analysis leads to the conclusion that
outcome was not a continuous function of protein nutrition and
the level of dialysis as they were prescribed in the study,
although highly significant continuous statistical functions
could be derived. When outcome is analyzed as a function of
the Kt/V analogue of pcr and BUN, it can be seen that the
apparent continuous function derives from the data distributing
essentially as two point clusters widely separated on both
ordinate and abscissa. The statistical model is based on the
assumption of a continuous function of outcome on the pcr,
CO2 analogue of Kt/V.
There are significant clinical implications of these differing
analytic results. The statistical model leads to the conclusions
that in patients with pcr < .80, there is a high incidence of poor
clinical results due to inadequate protein nutrition and that
these patients will not be benefitted by increasing dialysis. The
mechanistic analysis shows that all patients in the study with
pcr < .80 received greatly reduced dialysis (Kt/V < .70) and
leads to the conclusion that there is a high probability of failure
with Kt/V < .70 at all levels of pcr. Since no patients with pcr
< .80 were treated with higher Kt/V values, it is concluded
mechanistically that the relative importance of dialysis and
nutrition in low pcr patients cannot be judged from this study.
It is therefore not possible to provide clear recommendations
for management of low pcr patients. It can be recommended
that Kt/V should not be reduced below 0.9 (which would result
in quite low BUNs of 30 to 40 mg/dl at pcr =
.6). It would be
desirable to increase dietary protein intake if possible and move
the therapy coordinates into the adequate zone of Figure 7, but,
in our experience, -- 15% of patients have persistently low pcr
values and are very resistant to dietary manipulation. In these
patients, it would seem reasonable to provide a level of dialysis
sufficient to maintain the coordinates of therapy in Domain A of
Figure 7. Further research would appear to be necessary to
determine the dependence of outcome on the levels of dialysis
and protein intake in this undefined therapeutic domain.
The two models also differ with regard to prediction of an
adequate dialysis prescription. The authors caution against
quantitative use of the statistical model to estimate the proba-
bility of treatment failure in an individual patient and recom-
mend only that an adequate protein intake be prescribed and
TAC held in the range common to the group 1,3 patients [4].
However, the statistical model does clearly predict that, all else
being constant, the mean probability of failure continuously
diminishes as therapy coordinates move to the lower right-hand
corner of Figure SB, a domain of high protein intake and
intensive dialysis. Thus, the conceptual implication of the
statistical model is that the optimal therapy prescription would
be comprised of high protein intake and intensive dialysis.
The mechanistic model indicates the probabiilty of therapy
failure does not decrease as Kt/V increases from 0.9 to 1.5 in
proportion to pcr, increasing from 0.8 to 1.4 (Figs 4 and 7).
Consequently, it is concluded that a fully adequate dialysis
prescription is provided with pcr = 1.0 and Kt/V = 1.0 (a level
of treatment that is 25% greater than the step function value in
Fig. 4) and that prescribing higher levels of these nutritional and
dialysis parameters are of no apparent clinical value with the
cellulosic dialyzers in current use on a thrice weekly treatment
schedule.
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Appendix
The rigorous variable volume urea model was used to design
and control the NCDS [5]. However, some important general-
ized relationships between treatment variables can be shown
from a truncated version of the model assuming fixed volume,
no urea generation during dialysis, and a symmetric thrice
weekly treatment schedule. The concentration relationships
during dialysis with these assumptions is given by
(1) Ct=CO
V
where CO = predialysis BUN,mg/ml;
CT = post dialysis BUN; K = clearance, mI/mm;
= length of dialysis, mm;
V = urea distribution volume, ml.
Rearrangements of Eq(1) and subtraction of CO from both
sides results in
CO - Ct CO(l -
V
The term CO-Ct describes the change in BUN during dialysis
(SC) and in steady-state therapy must be equal to the
interdialytic rise in BUN. Thus, Eq(2) can also be written as
C=CO(l V
Equation (3) can now be developed to examine some inter-
relations between treatment variables. The assumption of a
symmetrical schedule will result in constant CO if urea gener-
ation (SC) and the magnitude of dialysis (Kt/V) remain constant
so that CO can be considered to be the target mid-week
predialysis BUN or CO2. Solution of Eq(3) for Kt and KtJV
results in




— ml i — —
V \ CO
The total magnitude of therapy prescribed is Kt while the
normalized value is Kt/V. To examine the interactions between





534 Gotch and Sargent
The total protein catabolic rate (PCR, glday) is calculated
directly from the net urea generation rate (G, mg/mm), and G is
calculated from the product of iC and V divided by the
interdialytic time interval (0). An average value for 0 can be
calculated to be 2646 minutes, assuming symmetrical thrice





The PCR is calculated from the relationship
(7) PCR = 9.35G + .00028V
Combining Eqs (6) and (7) results in
(11) — fl( — .49pcr — .16V \ CO
Equation (11) shows how Kt/V was prescribed in the NCDS
as a function of pcr and CO. The implications of this relation-
ship are discussed in the paper.
It is also useful to solve Eq(11) for CO2 which results in
(12) CO2 .49 [1/(1 — (pcr — .16)
Equation (12) indicates that whenn KtIV is held constant, CO
will increase linearly with pcr. The significance of this relation-
ship is discussed in the paper.
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(8) PCR = .O035CV + .00028V
The relationship between PCR and normalized value pcr,
g/kg/day is
PCR IPCR(9) pcr— = .58Vf.58 V
where V is expressed in liters and the body
is considered to be 58% water or .58 liter/kg.
Combination of Eqs (8) and (9) and reconciliation of units
results in
(10) pcr = 2.03C + .16
Equation (10) shows that pcr is related to zC by numerical
constants and Eq(5) can be written as
